Relacorilant (Rela) With Nab-Paclitaxel (Np): Safety And Activity In Patients With Pancreatic Ductal Adenocarcinoma (Pdac) And Ovarian Cancer (Ovca).
JOURNAL OF CLINICAL ONCOLOGY(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2019)